Get started
Author

Elif Sahin

Observed name: Elif Şahin
ORCID: 0000-0002-1976-3951
Observed ORCID: 0000-0002-1976-3951
OpenAlex ID: A5135534659
First-Line Treatment After Perioperative FLOT in Recurrent Gastric and Gastroesophageal Junction Cancer: A Turkish Oncology Group (TOG) Multicenter Real-World Analysis
2026 · Mustafa Seyyar, Pervin Can Şancı, et al. · Medicina · 1
Comparison of flat-dose versus weight-based dose nivolumab treatment in NSCLC patients
2026 · Muhammet Cengiz, Oktay Bozkurt, et al. · Scientific Reports · 1
PDF
Prognostic Impact and Clinicopathological Correlates of HER2 Status in Gastric Cancer: A Multicenter Retrospective Turkish Oncology Group Study
2026 · Sedat Yildirim, Ozlem Nuray Sever, et al. · Clinical Medicine Insights Oncology · 1
Real-World Treatment Patterns and Survival in Uveal Melanoma: A Multicenter Cohort Study by the Turkish Oncology Group (TOG)
2026 · Sercan On, Selin Cebeci, et al. · Cancers · 1
PDF
Real-world outcomes of second-line therapy in advanced thymic carcinoma: a multicenter Turkish Oncology Group (TOG) study
2026 · Fatih Kus, Fatih Atalah, et al. · BMC Cancer
Impact of adjuvant endocrine therapy on disease-free survival in early triple-positive breast cancer: a multicenter retrospective cohort study of the Turkish oncology group
2026 · Mustafa Seyyar, Pervin Can Şancı, et al. · BMC Cancer
Real-World Outcomes and Progression Patterns with First-Line Osimertinib in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Nationwide Turkish Oncology Group Study
2026 · Bahadır Köylü, Özde Melisa Celayir, et al. · Cancers
Clinical outcomes of adjuvant treatment strategies in locally advanced gastroesophageal and gastric adenocarcinoma with poor pathological response to neoadjuvant FLOT: A Turkish Oncology Group (TOG) study.
2026 · Atilla Çiftçi, Özlem Kutlu, et al. · Journal of Clinical Oncology
PDF
Prognostic Value of the Prognostic Nutritional Index in Patients with Locally Advanced Bladder Cancer Receiving Perioperative Chemotherapy: A Multicenter Real-World Study
2026 · Anıl Karakayalı, Mustafa Seyyar, et al. · Medicina
Prognostic value of the Scottish Inflammatory Prognostic Score in advanced NSCLC treated with second-line nivolumab
2026 · Erdem Kolemen, Kazım Uygun, et al. · Discover Oncology
Side Effect Management of Immune-related Hepatotoxicity Due to Immune Checkpoint Inhibitors: A Multicenter Study by the Turkish Oncology Group (TOG)
2026 · Ozden Demir, Bulent Cetin, et al. · Journal of Immunotherapy
Works count: 11
Citation count: 4
H-index: 1
I10-index:
Year
Topic
Type